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Abstract
Introduction Due to its proximity with the brain, cere-
brospinal fluid (CSF) could be a medium of choice for the
discovery of biomarkers of neurological and psychiatric
diseases using untargeted analytical approaches.
Objectives This study explored the CSF lipidome in order
to generate a robust mass spectral database using an
untargeted lipidomic approach.
Methods Cerebrospinal fluid samples from 45 individuals
were analyzed by liquid chromatography coupled to high-
resolution mass spectrometry method (LC-HRMS). A
dedicated data processing workflow was implemented
using XCMS software and adapted filters to select reliable
features. In addition, an automatic annotation using an in
silico lipid database and several MS/MS experiments were
performed to identify CSF lipid species.
Results Using this complete workflow, 771 analytically
relevant monoisotopic lipid species corresponding to 550
unique lipids which represent five major lipid families (i.e.,
free fatty acids, sphingolipids, glycerophospholipids,
glycerolipids, and sterol lipids) were detected and anno-
tated. In addition, MS/MS experiments enabled to improve
the annotation of 304 lipid species. Thanks to LC-HRMS,
it was possible to discriminate between isobaric and also
isomeric lipid species; and interestingly, our study showed
that isobaric ions represent about 50 % of the total anno-
tated lipid species in the human CSF.
Conclusion This work provides an extensive LC/HRMS
database of the human CSF lipidome which constitutes a
relevant foundation for future studies aimed at finding
biomarkers of neurological disorders.
Keywords Lipidomics  High resolution mass
spectrometry  Neurological disorders  Biomarker
discovery  Cerebrospinal fluid  Bioinformatics
1 Introduction
Lipids are essential cellular constituents that have many
critical roles in cellular functions. They are involved in
energy storage, cell signaling as second messengers, and
are major constituents of cell plasma membranes including
lipid rafts (Simons and Toomre 2000). Their crucial role is
highlighted by their involvement in a large number of
heterogeneous diseases such as cancer, diabetes, neuro-
logical disorders and inherited metabolic diseases (Wenk
2005; Lamari et al. 2013). Abnormal concentrations of
lipids are especially observed in various neurological dis-
orders, including neurodegenerative conditions such as
Alzheimer’s or Parkinson’s diseases and neurometabolic
disorders (Han et al. 2002; Adibhatla et al. 2006; Colsch
et al. 2008; Ariga et al. 2008; Haughey et al. 2010).
Due to the high structural diversity of lipid species
arising from various combinations of fatty acyls and func-
tional headgroups, the presence of isomeric and isobaric (i.e.,
species having the same nominal mass but distinct exact
masses) lipid species, and their occurrence at a large con-
centration scale, a complete lipidomic profiling of biological
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matrices remains a challenge. The first analysis of complex
lipid mixtures by mass spectrometry (MS) was introduced in
1990s by Han and Gross (1994). Since that time, improve-
ments in MS instrumentation in terms of mass resolution,
mass accuracy and duty cycles have expanded research in the
field of lipidomics. In targeted approaches, the overall plat-
form, i.e., sample preparation andMS detection is optimized
for a predetermined number of lipid classes or sub-classes.
These methods are mainly based on low resolution triple
quadrupole (TQ) operated in precursor–ion scanning, neutral
loss scanning or product ion modes. They offer high sensi-
tivity and have successfully been applied to the lipid profil-
ing of various biomaterials (Han and Cheng 2005; Han and
Gross 2005; Quehenberger et al. 2010). A remarkable con-
tribution in this field was the work of Quehenberger et al.
(2010), who have quantified over 500 distinct molecular
species distributed among the main lipid categories in
plasma samples (Quehenberger et al. 2010). However,
numerous targeted methods were necessary to achieve this
broad lipidome coverage, thus limiting throughput capabil-
ities of such approaches.
By enabling accurate mass measurements with sup-ppm
errors, high resolution mass spectrometers (HRMS), which
include Fourier transform ion cyclotron resonance (FTICR),
Orbitrap, and Time-of-flight (TOF) instruments, have
prompted the use of untargeted lipidomic approaches
(Ejsing et al. 2009; Schwudke et al. 2011; Guo et al. 2012; Li
et al. 2013;) through affording the possibility to separate
isobaric lipid species. Using HRMS instruments, ‘‘shotgun
approaches’’, based on direct introduction of a total lipid
extract into the mass spectrometer, have been developed for
global lipidomic analysis and enable the measurement of
several hundred of lipid species covering the 21 major lipid
classes from yeast extracts (Ejsing et al. 2009). However,
although these methods without prior chromatographic
separation are fast and simple, their sensitivity is limited by
major ion suppression effects and the lack of discrimination
between isomeric lipid species (Han and Gross 2005).
As an alternative approach, liquid chromatography
coupled to high-resolution mass spectrometry (LC-HRMS)
can be used to improve the sensitivity (Bird et al. 2011;
Junot et al. 2014) and facilitate the detection of minor lipid
species. Furthermore, LC also enhances the separation of
isomeric lipid species (Lee et al. 2011; Bird et al. 2012).
These LC-HRMS-based global methods enable to achieve
a broad lipidome coverage with detection and relative
quantification of several hundred unique lipid species in a
single experiment (Gregory et al. 2013).
However, dedicated informatic tools are required in
order to handle of the huge quantity of data generated by
LC/HRMS systems. Before automatic detection and
annotation, raw data must be converted into data formats
compatible with peak detection and alignment software
tools such as MZmine (Katajamaa et al. 2006) or XCMS
(Smith et al. 2012). Thanks to accurate mass measurements
provided by HRMS, lipidomic features can be annotated by
using lipid databases such as that of the LIPID MAPS
consortium (Fahy et al. 2005), which introduced the
‘‘Comprehensive Classification System for Lipids’’. This
classification system aims to catalog lipid species and
makes available online tools to support lipid identifications.
More recently, the LipidBlast in silico tandem mass spec-
tral database has been implemented and covers compounds
of 26 lipid classes (Kind et al. 2013). In parallel, manu-
facturers have also developed commercial software tools,
such as Lipid Search from ThermoFisher Scientific
(Taguchi and Ishikawa 2010), Lipid View from AB Sciex
(Ejsing et al. 2006) or SimLipid from Premier Biosoft, for
direct annotation from raw data. However, reliable lipi-
domic data treatment workflows able to handle the detec-
tion and alignment of features, together with selection and
annotation of analytically reliable ones, are still emerging.
Lipidomic profiles of human biological materials for
biomarkers discovery are mostly performed in plasma
(Quehenberger et al. 2010; Pizarro et al. 2013), cell or tissue
extracts (Han and Cheng 2005; Ejsing et al. 2009), and to a
lesser extent in urine (Touboul et al. 2005; Cui et al. 2008).
Regarding neurological and psychiatric disorders, cere-
brospinal fluid (CSF) could be a very informative fluid due to
its constant physical contact with the brain. However, the
total lipid content of human CSF appears to be low, with
concentrations around 10–13 lg mL-1, according to previ-
ous studies performed on healthy individuals. This repre-
sents about 0.2 % of serum total lipid content (Irani 2009)
with a huge heterogeneity of lipid species. For this reason,
very few lipidomic studies have been conducted on CSF and
most of them have been achieved using targeted methods
focused on selected lipid families (Colsch et al. 2015), such
as free fatty acids and their derivatives (Farias et al. 2011;
Fonteh et al. 2014), glycerophospholipids, sphingomyelins,
sterols (Tourtellotte 1959; Illingworth and Glover 1971) and
phospholipid families (Mudler et al. 2003; Kosicek et al.
2010; Kosicek et al. 2012; Fonteh et al. 2013).
In this context, the objective of this workwas to develop and
validate an untargeted lipidomic approach by using UHPLC/
HRMS, to implement a dedicated data processing workflow
and to performcomplementaryMS/MSexperiments in order to
provide an extensive annotation of human CSF lipidome.
2 Materials and methods
2.1 CSF samples
CSF samples from 43 subjects including 35 patients with
unknown neurological disturbances and eight patients
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without observed neurological signs (control CSF samples)
were collected by Drs. F. Sedel and F. Lamari of the Pitie-
Salpetriere Hospital (Paris, France) in the frame of the
SPECMET 2 study (PHRC Grant number AOM 10300),
with the agreement of the local ethics committee for clin-
ical research studies. This cohort was designed in order to
obtain the most representative structural diversity of lipid
species in CSF samples. A quality control (QC) sample
consisting of a mixture of equal aliquots of all samples
included in this study was injected every ten samples.
These QC samples were extracted and then injected in
triplicate after successive dilutions from 2 to 8 at the
beginning of the running sequence after blank series with
and without internal standards in order to check the per-
formances of the analytical system and to validate the
reliability of the detected features.
2.2 Reagents
LC–MS grade water (H2O) and methanol (MeOH) were
from VWR International (Plainview, NY). HPLC grade
ammonium formate, chloroform, 2-propanol (IPA) and
formic acid were from Sigma-Aldrich (Sigma Chemical
Co., St Louis, MO, USA). All internal standards used in
this study (see Table S1 of the supplemental data) were
purchased from Avanti Polar Lipids, Inc (Alabaster, AL).
2.3 Sample preparation
CSF lipids were extracted according to a modified Bligh and
Dyer method (Bligh and Dyer 1959). Briefly, 100 lL of CSF
was added to 490 lL of chloroform/methanol 50:50 (v/v) and
10 lL of internal standard mixture (IS; see Table S1 in
supplementary material). Samples were vortexed for 60 s and
then sonicated for 30 s using a sonication probe. Extraction
was performed after 2 h at ?4 C with mixing. In addition,
75 lL of ultra-pure water was added and samples were vor-
texed for 60 s before centrifugation at 4000 rpm for 10 min at
4 C. The upper phase (aqueous phase), containing gan-
glioside species and several lysophospholipids, was trans-
ferred into a glass tube and then dried under a stream of
nitrogen. The interphase which consists on a protein disk was
discarded and the lower rich-lipid phase (organic phase) was
pooled with the dried upper phase. Samples were then
reconstituted with 100 lL of MeOH/IPA/H2O 65:35:5 (v/v/
v), vortexed for 30 s and sonicated for 60 s before injection.
2.4 Liquid chromatography
The reversed phase chromatographic conditions were
adapted from Hu et al. (2008). Methanol was preferred to
acetonitrile since it has been observed that it decreased the
carryover of most apolar lipid species (data not shown).
CSF total lipid extracts were separated on an Dionex
Ultimate 3000 UPLC system (Thermo Scientific, San Jose,
CA) using a kinetex C8 150 9 2.1 mm, 2.6 lm column
(Phenomenex, Sydney, NSW, Australia). Mobile phase A
consisted of H2O/MeOH 60/40 (v/v) and 0.1 % formic acid
and mobile phase B of IPA/MeOH 90/10 (v/v) and 0.1 %
formic acid. Ammonium formate (10 mM) was added to
both mobile phases in the positive ion mode. The presence
of ammonium salt in mobile phases decrease drastically the
detection of sodium adducts which now constitute minor
lipid species in the positive ion mode (data not shown). The
gradient program was as follows: solvent B was maintained
for 2.5 min at 32 %, from 2.5 to 3.5 min it was increased to
45 % B, from 3.5 to 5 min to 52 % B, from 5 to 7 min to
58 % B, from 7 to 10 min to 66 % B, from 10 to 12 min to
70 % B, from 12 to 15 min to 75 % B, from 15 to 19 min
to 80 % B, from 19 to 22 min to 85 % B, and from 22 to
23 min to 95 % B; from 23 to 25 min, 95 % B was
maintained; from 25 to 26 min solvent B was decreased to
32 % and then maintained for 4 min for column re-equi-
libration. The flow rate was 400 lL/min and the column
temperature was set to 60 C.
2.5 Mass spectrometry
After injection of 10 lL of sample, the column effluent was
directly introduced into the heated Electrospray (HESI)
source of a Q-Exactive mass spectrometer (Thermo Sci-
entific, San Jose, CA) and analysis was performed in both
ionization modes in two separate runs. The HESI source
parameters were as follows: the spray voltage was set to
3.7 kV and -3.1 kV in positive and negative ionization
mode, respectively. The heated capillary was kept at
360 C and the sheath and auxiliary gas flow were set to 15
and 10 (arbitrary units), respectively. Mass spectra were
recorded in full-scan MS mode from m/z 50 to m/z 2000 at
a mass resolution of 140 k, full width at half-maximum
(FWHM) at m/z 200, and at a scan speed of 2 Hz. External
mass calibration was performed before analysis.
After LC-HRMS analysis of samples and annotation of
features, QC samples were re-injected for higher energy
collisional dissociation (HCD) MS/MS experiments in
positive and negative ion modes on the same instrument set
in targeted mode using inclusion lists. The isolation width
was set at m/z 1.5, the normalized collision energy was
25 % and the mass resolution was set at 17,500 FWHM at
m/z 200. HCD mass spectra were inspected manually in
order to confirm annotations.
2.6 Data processing
Raw files were first of all converted to mzXML format with
MSconvert (ProteoWizard). Peak detection, alignment and
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integration were performed with the XCMS software
package version 1.30.3 (Smith et al. 2006) including the
CentWave algorithm (Tautenhahn et al. 2008). The list of
the parameters used is available as supplementary material
(see Table S2 provided as supplementary material). A data
matrix was generated by the software. It contained the list
of all detected features, including information such as
accurate measured masses, retention times and areas of
chromatographic peaks.
3 Results and discussion
We first of all report on the development and validation of
a lipidomic method based on reversed phase liquid chro-
matography coupled to high-resolution mass spectrometry
(RPLC-HRMS). A data processing workflow was also
developed, including automatic peak detection and align-
ment using the XCMS package (Tautenhahn et al. 2008;
Smith et al. 2012), several filtration steps in order to obtain
a list of reliable features, and automatic feature annotation
which was achieved thanks to an in silico lipid database
developed in our laboratory (see Table S5 in supplemen-
tary material) and based on accurate measured masses,
retention time windows and relative isotopic abundance
(RIA) of lipid species. This lipidomic approach was then
used to analyze CSF samples collected from 43 individuals.
Finally, MS/MS experiments were performed in order to
improve lipid annotations.
3.1 Method development and validation
The eight lipid families established by the LIPID MAPS
Consortium represent a broad diversity of structure (Fahy
et al. 2009). As a consequence, the efficiency of any
untargeted lipidomic study rely on (i) the completeness and
reliability of lipid extraction, (ii) the versatility and the
sensitivity of the LC/MS profiling method, and on (iii)
associated data processing tools that are mandatory to
handle a huge amount of data.
3.1.1 Extraction recovery and repeatability
Using a modified Bligh and Dyer extraction conventionally
used to analyze major lipid families in biological matrices,
recoveries were calculated from CSF QC samples (n = 5)
spiked with 22 non endogenous internal standards (IS)
representing the five major lipid families (fatty acyls,
glycerophospholipids, glycerolipids, sphingolipids and
sterol lipids, see Table S1 provided as supplementary
material). Their corresponding chromatographic peak areas
were compared to those obtained from CSF extracts spiked
with the same internal standard mixture after extraction.
Using the described method, mean recoveries for the five
lipid families were all above 80 % (see Table S3 provided
as supplementary material): i.e., 88.2 % for fatty acyls,
90.6 % for sphingolipids, 80.6 % for glycerophospholipids
and 88.7 % for glycerolipids.
3.1.2 Assessment of the lipidome coverage provided
by the RPLC-HRMS method
Extracted ion chromatograms of IS spiked in CSF are
displayed in Fig. 1. Both positive (Fig. 1a) and negative
(Fig. 1b) electrospray ionization modes were used. As
expected, the addition of ammonium formate in the posi-
tive ion mode mobile phases enhanced the signal of neutral
lipid species (sterols, cholesteryl esters, MG, DG and TG
internal standards) and phosphatidic acids (PA and LPA),
which were detected as [M ? NH4]
? adducts (Murphy
et al. 2001). Thereby, the phosphatidylcholine (PC) internal
standard including its associated lyso-forms (LPC), cer-
amides (Cer), galactosylceramides (GalCer), lactosylce-
ramides (LacCer), and sphingomyelins (SM) were detected
as [M ? H]? ions, whereas the free fatty acids, phos-
phatidylethanolamine (PE), phosphatidylinositol (PI),
phosphatidylglycerol (PG), phosphatidylserine (PS) and
their lyso forms (LPE, LPI, LPG and LPS, respectively),
sulfatides (Su) and monosialo-gangliosides (SGL) were
detected as [M - H]- ions. Despite of the use of ammo-
nium formate, sodium adducts ([M ? Na]?) were detected
for some lipid classes, i.e., Cer, HexCer, SM, LPC, PC,
glycerolipids (DG and TG) and cholesteryl esters. Choline
containing lipid classes (SM, LPC and PC) were also
detected in the negative ion mode as formate adducts
([M - H ? CHO2]
-). Finally, water losses in the positive
ion mode ([M ? H - H2O]
?) were observed for Cer,
HexCer and DG lipid standards, as already described
(Christie and Han, 2010). All these pseudo-molecular,
adducts ions and in source fragments were added in the in
silico database to improve annotation confidence (see
Table S5 in supplementary material).
3.1.3 Validation of the RPLC-HRMS method
To assess its ability to detect changes in lipid profiles for
clinical application and biomarker discovery, the devel-
oped method was validated by intra-assay precision and
linearity studies performed on the internal standard
mixture.
The intra-assay precision (regarding chromatographic
peak areas and retention times) was evaluated by per-
forming five independent extractions of the CSF pools
spiked with the IS mixture (see Table S1, provided as
supplementary material, for their concentrations). Relative
standard deviations (RSDs) of chromatographic peak areas
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and retention times are shown in Table 1. Regarding peak
areas, standard deviation ranged from 2.8 % to 20.1 %
(average of 8.5 %). The lowest variations were obtained
for the sphingolipid and fatty acyls families with an aver-
age RSD of 3.9 and 5.8 %, respectively, whereas the
highest variations were found for neutral lipid families with
20.1 and 16.9 % for DG and TG species, respectively. In
addition, retention time variations of all standards were
also satisfactory with an average variation of 0.8 %.
CSF QC samples were also spiked with IS at five dif-
ferent concentrations ranging from 10 to 1000 ng.mL-1
(final concentrations, n = 3) in order to evaluate the lin-
earity of the method (Table 1). Most of the standards were
detected at the lowest concentration with regression coef-
ficients (r2) ranging from 0.979 to 0.999. LPA and TG
standards were detected from 50 ng.mL-1 with regression
coefficients of 0.979 and 0.935, respectively. A particular
behavior was observed for the cholesteryl ester internal
standard, which was detected at 10 ng.mL-1, but whose
linearity range started at 100 ng.mL-1.
3.1.4 Development of a data processing workflow
From these complex high-resolution raw data, automatic
detection of features (characterized by unique mass-to-
charge ratio and retention time) is a crucial step and has to
be reliable in order to detect as many ions as possible and
minimize false positives. To this end, a data processing
workflow including peak detection, selection of analyti-
cally relevant features and data set annotation was devel-
oped, as shown in Fig. 2.
Regarding peak detection, as preliminary works under-
taken at our laboratory and using the MatchedFilter algo-
rithm were not successful, we selected the already
implemented CentWave algorithm, another peak detection
algorithm (Tautenhahn et al. 2008). This algorithm is based
on the concomitant detection of mass traces (named
‘‘regions of interest (ROI)’’) and chromatographic peaks of
different widths, which is relevant in the context of a non-
targeted analysis of various lipid subclasses with different
chromatographic peak shapes. The main CentWave
parameters, i.e., the range of chromatographic peak width
and the signal-to-noise threshold for validation of features,
were carefully optimized by comparing false-negative and
false-positive rates for manually annotated datasets.
The reliability of the XCMS software in term of peak
integration was evaluated using chromatographic peaks
related to internal standards and endogenous lipids from
CSF samples spiked with the IS mixture. Areas of 164
chromatographic peaks (including 110 annotations corre-
sponding to internal standard signals and the 54 endoge-
nous lipids), ranging between four orders of magnitude,
and automatically detected by XCMS were compared with
those integrated by using Xcalibur (Thermo Fisher scien-
tifics, Courtaboeuf, France) via the QuantBrowser module
(ICIS algorithm). Results are shown in figure S1 in
Fig. 1 Extracted ion
chromatograms of the 22
internal standards detected
either in the positive (a) or in
the negative (b) ion mode
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supplementary material. The linear regression analysis
results were satisfactory with a coefficient of determination
above 0.999 (r2 = 1.000 and r2 = 0.999 with only the 20
less intense ions) and a slope of 1.000, which indicates that
automatic integration by XCMS performs well.
The XCMS output is a data matrix containing few
thousands of features, either specific to the sample set, or
corresponding to artifacts introduced by the LC–MS sys-
tem or the sample preparation. In order to select analyti-
cally relevant features, a peak table filtration step was
implemented according to the following criteria: (i) the
coefficient of correlation between serial dilutions of QC
samples (by factors of 1, 2, 4 and 8) and areas of the related
chromatographic peaks should be above 0.8, (ii) the coef-
ficients of variation of the areas of chromatographic peaks
of features in QC samples should be less than 30 %, and
(iii) the ratio of chromatographic area of biological to
blank samples should be above a value of 1.5.
Feature annotation was then achieved through the
implementation of an in silico database which contains
28,807 exact masses corresponding to pseudo-molecular
ions ([M ? H]?, [M - H]- and [M - 2H]2-), adducts
([M ? NH4]
?, [M ? Na]?, [M - H ? CHO2]
-), and in
source fragments ([M ? H - H2O]
?) ions of the five
major lipid families indexed in the LIPID MAPS library,
along with their corresponding 13C and double 13C iso-
topes. Furthermore, specific retention time windows for
each lipid class were also added by examining retention
times of species containing the longest and the shortest
fatty acyl chains (see Table S4 in supporting information).
Thanks to scripts developed in R language, exact masses of
XCMS detected features were matched to those of our in
silico database (±4 ppm). Annotations were kept if the
retention times of the corresponding features were within
the retention time window specific of their putative lipid
class.
Table 1 Evaluation of the repeatability, retention time variation and the linearity (from 10 to 1000 ng mL-1) of the 22 internal standards,
representative of the five lipid categories
Lipid category Repeatability (RSD, %) Retention time variation (RSD, %) Linearity R2
Free fatty acids
C14:0(OH) 5.8 1.1 0.997
Sphingolipids
d18:1/12:0 Cer 3.9 0.7 0.999
d18:1/12:0 GalCer 4.7 0.7 0.999
d18:1/12:0 lacCer 3.1 0.7 0.999
d18:1/12:0 Su 3.8 0.4 0.998
d18:0/12:0 SM 5.1 0.7 0.999
GM3 CD3 2.8 0.3 0.997
Glycerophospholipids
11:0 LPC 10.6 1.7 0.992
14:0 LPA 18.5 1.9 0.979 (50–1000 ng mL-1)
13:0 LPE 6.5 0.8 0.995
13:0 LPS 5.8 2 0.997
13:0 LPI 10.3 1.7 0.979
13:0 LPG 7.6 1 0.989
26:0 PC 10.6 0.7 0.985
24:0 PA 8.9 0.7 0.998
24:0 PE 6.5 0.2 0.990
34:1 D31 PS 4.9 0.2 0.996
36:0 PI 7.8 0.4 0.986
24:0 PG 7.8 0.4 0.994
Glycerolipids
1,3-28:0 D5 DG 20.1 0.7 0.974
60:1 D5 TG 16.9 0.5 0.935 (50–1000 ng mL-1)
Sterol lipids
22:0 cholesteryl ester 14.8 0.5 0.981 (100–1000 ng mL-1)
91 Page 6 of 14 A. Seyer et al.
123
However, accurate measured masses and retention time
windows were not sufficient to assess the relevance of lipid
species, and additional spectral information was required to
confirm annotations (Kind and Fiehn 2006; Erve et al.
2009; Xu et al. 2010). Annotated lipid species were thus
kept (i) if their 13C isotope was detected and aligned in
time (±5 s) and (ii) if all annotated signals corresponding
to the same lipid species (i.e., pseudo-molecular ions,
adduct ions and/or in source fragments, either as
monoisotopic or 13C and 2913C isotopes) must have the
same retention time as a reference ion (±5 s, and ±10 s
between two ionization modes after merging corresponding
peaktables).From the analysis of lipid standards spiked in
CSF, we were able to determine these reference ions which
correspond to the most intense ion of each lipid classes
(i.e., pseudo-molecular ions or adduct ions, depending on
the lipid class, see Table S5 in the supplementary material).
In addition, the relative isotopic abundance (RIA) between
the monoisotopic ion and its corresponding 13C isotope,
were automatically calculated according to Eq. (1) and
compared to theoretical ones. Annotated lipid species with
a RIA error higher than 30 % were filtered out. This
threshold of 30 % was selected since RIA errors of all
internal standards were below this value (see figure S2 in
supporting information).
RIA error %ð Þ ¼ 100 RIAexp RIAtheo
RIAtheo
ð1Þ
3.2 Annotation of the human CSF lipidome
The RPLC-HRMS based lipidomic method and its asso-
ciated data processing workflow were applied to the
analysis of 43 human CSF samples. From complex LC/
HRMS raw data, 51,449 features were generated in
combined positive and negative ion modes by the XCMS/
Centwave process, among which 32,478 were found to be
analytically relevant (i.e., satisfaction values including
dilution factors of coefficient variation between QC
samples and ratio of chromatographic area of biological
to blank samples). Then, 771 features were annotated,
corresponding to pseudo-molecular, in-source fragment
and adducts ions, as shown in Table 2. Of these annota-
tions, 550 features were attributed to unique lipid species.
This result emphasizes that many reliable features are not
annotated by our in silico database and remain to be
identified.
Endogenous lipid species were detected by ESI–MS
under different ionic forms such as [M ? H]? and
[M - H]- ions, but also adduct ions such as [M ? NH4]
?,
[M ? Na] ?, [M - H ? CHO2]
- and in source-fragment
ions [M ? H - H2O]
?, as observed for lipid standards.
Interestingly, gangliosides were detected as singly charged
[M - H]– ions for monosialoganglioside species, and also
as doubly charged [M - 2H]2- ions with two to four
attached sialic acid molecules. The five major lipid families
were represented and annotated in both positive and nega-
tive ionization modes, including 13 fatty acyls (9 fatty acids
and 4 fatty amides), 108 sphingolipids (2 sphingoı¨d bases,
27 ceramides, 14 hexosylceramides, 20 sulfatides, 28 sph-
ingomyelins and 17 gangliosides), 256 glycerophospho-
lipids (117 PC, 7 PA, 39 PE, 46 PS, 12 PI, 5 PG and their
corresponding lyso-forms: 16 LPC, 4 LPE, 2 LPS, 5 LPI, 3
LPG), 156 glycerolipids (35 diacylglycerols and 121 tria-
cylglycerols) and 17 sterols and steryl-esters (cholesterol
and cholesteryl-esters).
Liquid chromatography coupled to ultra-high resolution
mass spectrometry (i.e., mass resolution power higher than
100 k, FWHM at m/z 200) was of special interest to dis-
tinguish isobaric and isomeric lipid species. Furthermore,
• Coefficient of correlation > 0.8,
• Coefficient of variations < 30 %,
• Ratio of chromatographic area of biological to 
blank samples > 1.5
1. XCMS peak detection and alignment
3. Automatic annotation
4. Selection of relevant lipid species
DATA PROCESSING STEPS
• Mass deviation < 4 ppm,
• Retention time range for each lipid class
•
13
C isotope detected at the same retention time 
(tolerance +/- 5 sec) as that of the monoisotopic ion,
• Pseudo-molecular, fragment and adduct ions at the 
same retention time as that of the monoisotopic ion 
(tolerance +/- 5 sec, and +/- 10 sec after the fusion of 
the two peaktables obtained from positive and 
negative ion  modes),
• Relative isotopic abundance error (RIA) < 30 %
2. Selection of reliable features
5. MS/MS experiments
Fig. 2 The data processing workflow. Features were filtered accord-
ing to the following criteria: (i) the coefficients of correlation between
dilution factors of QC samples (by factors of 1, 2, 4 and 8) and areas
of chromatographic peaks (above 0.8), (ii) the coefficients of variation
of areas of chromatographic peaks related to features detected in QC
samples (less than 30 %) and (iii) the ratio of chromatographic areas
of biological to blank samples (more than a factor of 1.5). Features
were then annotated using a spectral database on the bases of exact
masses and retention time windows specific to each lipid family. Each
unique lipid species must be detected by XCMS/CentWave with at
least its corresponding 13C isotope, and eventually fragment and
adduct ions, which must be eluted at the same retention time as that of
the pseudo molecular ion (with a tolerance of ±5 s, and ±10 s after
the fusion of the two peaktables obtained in the positive and negative
ion modes). Finally, each lipid species must have a RIA error below
30 %
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MS/MS experiments were used to improve the annotation
of lipid species.
3.2.1 Discrimination of isobaric lipid species
The presence of numerous isobaric lipid species is one the
most challenging issue for a reliable lipidome annotation
(Schwudke et al. 2011). Indeed, lipid species can be
detected under different ionization forms and it is common
to detect different lipid species belonging to different
classes with the same nominal mass, but with distinct exact
masses.
As an example, an extracted ion chromatogram between
8 and 10 min is shown in Fig. 3a, with the simultaneous
detection of the deprotonated ion [M - H]- corresponding
to the PI38a:4 at m/z 885.5521 and its 13C isotope at m/z
886.5551. Furthermore, another isobaric deprotonated
[M-H]- ion corresponding to the sulfatide lipid species
(d18:2/C24:1) was also detected at m/z 886.6099. The use
of UHPLC enabled to separate these two isobaric species,
with retention times at 8.6 min for the PI (Fig. 3b) and
9.1 min for the sulfatide (Fig. 3c), respectively. The iden-
tity of the sulfatide lipid species was then confirmed by
MS/MS experiments by the presence of the characteristic
m/z 97.1044 ion corresponding to the sulfate group (see
Table S4 provided as supplementary material) already
found in mammalian brain (Colsch et al. 2004).
Our data showed that isobaric ions represent about 50 %
of the 771 annotated lipid species in human CSF.
This emphasizes the limit of using shotgun approaches and
reinforces the relevance of using liquid chromato-
graphic methods in complement to high resolution mass
spectrometry.
3.2.2 MS/MS experiments improved the annotation of lipid
species
The reliable characterization of the detected lipid species
represents a critical issue for a global lipidomic approach.
The implementation of our LC/HRMS method coupled to a
data processing workflow enabled the annotation of 771
features corresponding to 550 unique lipid species in
human CSF. MS/MS experiments were conducted on a QC
sample using inclusion lists in both positive and negative
ion modes in order to improve these annotations.
The detection of some particular lipid species such as
LPC/PC and SM in both positive and negative ionization
modes, as protonated ion ([M ? H]?) and formate adduct
([M - H ? CHO2]
-), enabled to confirm their annotation
and also improved their structural characterization. This is
for example displayed in Fig. 4 for PC34a:1. After having
checked that all the ions related to this lipid species were
eluted at the same retention time (at 9.1 min) in both
positive and negative ion modes (Fig. 4a, b), MS/MS
Fig. 3 Extracted ion chromatogram between 8 and 10 min, obtained
from detection in the negative ionization mode (a). Thanks to the
implementation of an UHPLC method, two isobaric ions can be
separated. The first one at 8.6 min (b) corresponds to the 13C isotope
of PI38a:4, at m/z 886.5551, and the second one at 9.1 min (c) to the
deprotonated ion of sulfatide d18:2/C24:1, at m/z 886.6099
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fragmentation of the [M ? H]? ion atm/z 760.5844 enabled
to confirm the presence of the phosphocholine polar head
thanks to the characteristic fragment ions at m/z 184.0726,
m/z 104.1070 and m/z 86.0966 (Fig. 4c) (Murphy and
Axelsen 2011). Furthermore, in negative ion mode, the
fragmentation of the formate adduct ([M - H ? CHO2]
-)
ion related to this PC34a:1 species led to an [M - 15]- ion
corresponding to a neutral loss of a methyl group (Harrison
and Murphy 1995) detected at m/z 744.5555 and enable the
detection of the two fatty acids FAC18:1 (m/z 281.2487) and
FA C16:0 (m/z 255.2329) of this lipid species (Fig. 3d), thus
confirming the annotation proposal.
3.2.3 MS/MS experiments enabled to distinguish isomeric
lipid species
The characterization of isomeric lipid species constitutes
another critical issue, not only of ‘‘shotgun lipidomic
approaches’’, but also of hyphenated liquid chromatography
coupled mass spectrometry. This issue can be solved for TG
lipid species by increasing collision energy to refine their
structural characterization (Bird et al. 2011), and also for a
few other lipid species such as particular glycerophospho-
lipid species containing alkyl or alkenyl fatty acyl moieties.
For example, two kinds of annotations are proposed for the
protonated [M ? H]? ions detected atm/z 718.5738 andm/z
718.5535, at 9.0 and 9.3 min respectively: PC32e:1(alkyl–
acyl) or PC32p:0(alkenyl-acyl) (Fig. 5a). Structural char-
acterizations of these lipid species were achieved by per-
forming MS/MS experiments on [M ? H] ? and [M -
H ? CHO2]
- (m/z 740.5550 and 740.5556) ions in positive
and negative ion modes, respectively. Only fragmentation
experiments in the negative ion mode enabled to distinguish
between the alkyl-acyl form PC32e:1 by the presence of the
FA 16:1 (m/z 253.2172) at 9.0 min (Fig. 5b) and the alkenyl-
acyl form PC32p:0 by the presence of the FA 16:0 (m/z
255.2327) at 9.3 min (Fig. 5c).
Finally, informative MS/MS experiments led to the
confirmation of 418 out of the 771 annotated lipid species,
corresponding to 304 unique lipid species. These 771
annotated lipid species are displayed in the supplementary
material section (Table S4). Table S4 also displays their
Fig. 4 Extracted ion chromatograms of the PC34a:1 lipid species.
The [M ? H]? ion at m/z 760.5844 (a), and the [M - H ? CHO2]
-
ion at m/z 804.5778 (b) were detected in the same retention time
range (9.1 min ± 10 s), in the positive and negative ion mode,
respectively. The CID mass spectrum of the protonated [M ? H]? ion
confirmed the presence of the phosphocholine polar head (c), whereas
the CID mass spectrum of the formate adduct [M - H ? CHO2]
- ion
enabled the detection of the two FA C18:1 (m/z 281.2487) and FA
C16:0 (m/z 255.2329) associated fatty acids (d), leading to an
improved structural characterization of this lipid species
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exact masse, retention time, mass accuracy, and RIA
errors. It also includes intra-assay precision results
obtained for each lipid species in QC samples, fragment
ions observed during MS/MS experiments, and at last two
proposed level of annotation: (i) exact mass, retention time
and validated MS/MS experiments (level a) and (ii) exact
mass and retention time (level b). This list constitutes to
our knowledge the largest database of unique lipid species
found in human CSF.
Unlike metabolomics, very few standards of lipid spe-
cies are available compare to the huge amount of
endogenous lipid species present in complex biological
matrices. According to the metabolomics standards initia-
tive (MSI), annotations in untargeted lipidomic studies
correspond to putatively annotated compounds (level 2 of
identification) or putatively characterized compound clas-
ses (level 3 of identification) (Sumner et al. 2007). In
addition, the high level of structural precision provided by
public lipid databases cannot be achieved using a single
analytical method, (e.g., double bonds localization or cis–
trans isomerism) and without appropriates internal
standards.
When compared to previous studies conducted in human
CSF samples using ESI mass spectrometry, most of the
major lipid families such as glycerophospholipids (Mudler
et al. 2003; Kosicek et al. 2010; Kosicek et al. 2012;
Fonteh et al. 2013), sphingomyelins, sterols and free fatty
acids (Tourtellotte 1959), that are usually analyzed by
several complementary targeted methods, were detected in
a single experiment thanks to our global approach. Sph-
ingolipids, which represent less than 20 % of total lipid
species in CSF, are of particular importance in the context
of biomarker discovery for neurological diseases, such as
lysosomal or unknown neurometabolic diseases. Numerous
rare diseases involving the different steps of sphingolipid
biosynthesis pathway, from de-novo synthesis of ceramides
to the biosynthesis of complex lipids such as gangliosides
and sulfatides, have already been described (Han et al.
2003; Kolter and Sandhoff 2006; Gu et al. 2008; Mielke
et al. 2010; Fan et al. 2013). As no lists of lipid species
were provided in these studies, it is unfortunately not
possible to compare the number and nature of lipid species
detected using our method to those obtained with the pre-
vious ones. Furthermore, in addition to the annotated lipid
species, more than 20,000 features remain unannotated but
are analytically relevant for statistical analysis in the frame
of an untargeted lipidomic strategy.
4 Conclusion
We have developed and validated an untargeted lipidomic
approach enabling to profile, annotate and characterize
numerous lipid species, including isobars and isomers, in
Fig. 5 Extracted ion chromatograms of two isomeric lipid species
obtained at 9.0 and 9.3 min (a). CID mass spectra of these two ions in
the positive ionization mode shows the same fragmentation pattern,
with the characteristic fragment of phosphocholine at m/z 184.0727.
Additional CID spectra performed in the negative ionization mode
enabled to determine the presence of the fatty acids FA 16:1 (m/z
253.2172) (b) and FA 16:0 (m/z 255.2327) (c), corresponding to two
distinct PC species, namely alkyl–acyl-PC 32e:1 and alkenyl–acyl-
PC32p:0
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human CSF samples. Our method enabled the detection of
more than 30,000 reliable features suitable for statistical
analysis, among which 550 were annotated as unique
monoisotopic lipid species using annotation tools. Thanks
to tandem mass spectrometry experiments, 304 annotations
of distinct lipid species were improved in both positive and
negative ion modes. Finally, our study provides an exten-
sive database of the human CSF lipidome which is avail-
able to the scientific community. It constitutes a relevant
foundation for future studies aimed at finding biomarkers
of neurological disorders.
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